Mengfei Yang , Xiuying Zhang , Qing Liu , Yongxue Wang
{"title":"网络药理学、分子对接和非靶向代谢组学揭示清瘟通络膏改善呼吸道合胞病毒肺炎多靶点效应的分子机制","authors":"Mengfei Yang , Xiuying Zhang , Qing Liu , Yongxue Wang","doi":"10.1016/j.chmed.2024.07.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Qingfei Tongluo Plaster (QFP), an improved Chinese medicine hospital preparation, is an attractive treatment option due to its well clinical efficacy, convenience, economy, and patient compliance in the treatment of respiratory syncytial virus (RSV) pneumonia. The aim of this study was to investigate the efficacy mechanism of QFP on RSV rats from the perspective of alleviating lung inflammation and further explore the changes of serum metabolites and metabolic pathways in RSV rats under the influence of QFP.</div></div><div><h3>Methods</h3><div>This study used network pharmacological methods and molecular docking combined with molecular biology and metabolomics from multi-dimensional perspectives to screen and verify the therapeutic targets. Open online databases were used to speculate the gene targets of efficient ingredients and diseases. Then, we used the String database to examine the fundamental interaction of common targets of drugs and diseases. An online enrichment analysis was performed to predict the functional pathways. Molecular docking was applied to discover the binding modes between essential ingredients and crucial gene targets. Finally, we demonstrated the anti-inflammatory ability of QFP in the RSV-evoked pneumonia rat model and explained the mechanism in combination with the metabolomics results.</div></div><div><h3>Results</h3><div>There were 19 critical targets defined as the core targets: tumor necrosis factor (<em>TNF</em>), inducible nitric oxide synthase 2 (<em>NOS2</em>), mitogen-activated protein kinase 14 (<em>MAPK14</em>), g1/S-specific cyclin-D1 (<em>CCND1</em>), signal transducer and activator of transcription 1-alpha/beta (<em>STAT1</em>), proto-oncogene tyrosine-protein kinase Src (<em>SRC</em>), cellular tumor antigen p53 (<em>TP53</em>), interleukin-6 (<em>IL6</em>), hypoxia-inducible factor 1-alpha (<em>HIF1A</em>), RAC-alpha serine/threonine-protein kinase (<em>AKT1</em>), signal transducer and activator of transcription 3 (<em>STAT3</em>), heat shock protein HSP 90-alpha (<em>HSP90AA1</em>), tyrosine-protein kinase JAK2 (<em>JAK2</em>), cyclin-dependent kinase inhibitor 1 (<em>CDKN1A</em>), mitogen-activated protein kinase 3 (<em>MAPK3</em>), epidermal growth factor receptor (<em>EGFR</em>), myc proto-oncogene protein (<em>MYC</em>), protein c-Fos (<em>FOS</em>) and transcription factor p65 (<em>RELA</em>). QFP treated RSV pneumonia mainly through the phosphatidylinositol 3-kinase (PI3K)/RAC AKT pathway, HIF-1 pathway, IL-17 pathway, TNF pathway, and MAPK pathway. Animal experiments proved that QFP could effectively ameliorate RSV-induced pulmonary inflammation. A total of 28 metabolites underwent significant changes in the QFP treatment, and there are four metabolic pathways consistent with the KEGG pathway analyzed by network pharmacology, suggesting that they may be critical processes related to treatment.</div></div><div><h3>Conclusion</h3><div>These results provide essential perspicacity into the mechanisms of action of QFP as a promising anti-RSV drug.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 4","pages":"Pages 638-655"},"PeriodicalIF":4.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Network pharmacology, molecular docking, and untargeted metabolomics reveal molecular mechanisms of multi-targets effects of Qingfei Tongluo Plaster improving respiratory syncytial virus pneumonia\",\"authors\":\"Mengfei Yang , Xiuying Zhang , Qing Liu , Yongxue Wang\",\"doi\":\"10.1016/j.chmed.2024.07.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>Qingfei Tongluo Plaster (QFP), an improved Chinese medicine hospital preparation, is an attractive treatment option due to its well clinical efficacy, convenience, economy, and patient compliance in the treatment of respiratory syncytial virus (RSV) pneumonia. The aim of this study was to investigate the efficacy mechanism of QFP on RSV rats from the perspective of alleviating lung inflammation and further explore the changes of serum metabolites and metabolic pathways in RSV rats under the influence of QFP.</div></div><div><h3>Methods</h3><div>This study used network pharmacological methods and molecular docking combined with molecular biology and metabolomics from multi-dimensional perspectives to screen and verify the therapeutic targets. Open online databases were used to speculate the gene targets of efficient ingredients and diseases. Then, we used the String database to examine the fundamental interaction of common targets of drugs and diseases. An online enrichment analysis was performed to predict the functional pathways. Molecular docking was applied to discover the binding modes between essential ingredients and crucial gene targets. Finally, we demonstrated the anti-inflammatory ability of QFP in the RSV-evoked pneumonia rat model and explained the mechanism in combination with the metabolomics results.</div></div><div><h3>Results</h3><div>There were 19 critical targets defined as the core targets: tumor necrosis factor (<em>TNF</em>), inducible nitric oxide synthase 2 (<em>NOS2</em>), mitogen-activated protein kinase 14 (<em>MAPK14</em>), g1/S-specific cyclin-D1 (<em>CCND1</em>), signal transducer and activator of transcription 1-alpha/beta (<em>STAT1</em>), proto-oncogene tyrosine-protein kinase Src (<em>SRC</em>), cellular tumor antigen p53 (<em>TP53</em>), interleukin-6 (<em>IL6</em>), hypoxia-inducible factor 1-alpha (<em>HIF1A</em>), RAC-alpha serine/threonine-protein kinase (<em>AKT1</em>), signal transducer and activator of transcription 3 (<em>STAT3</em>), heat shock protein HSP 90-alpha (<em>HSP90AA1</em>), tyrosine-protein kinase JAK2 (<em>JAK2</em>), cyclin-dependent kinase inhibitor 1 (<em>CDKN1A</em>), mitogen-activated protein kinase 3 (<em>MAPK3</em>), epidermal growth factor receptor (<em>EGFR</em>), myc proto-oncogene protein (<em>MYC</em>), protein c-Fos (<em>FOS</em>) and transcription factor p65 (<em>RELA</em>). QFP treated RSV pneumonia mainly through the phosphatidylinositol 3-kinase (PI3K)/RAC AKT pathway, HIF-1 pathway, IL-17 pathway, TNF pathway, and MAPK pathway. Animal experiments proved that QFP could effectively ameliorate RSV-induced pulmonary inflammation. A total of 28 metabolites underwent significant changes in the QFP treatment, and there are four metabolic pathways consistent with the KEGG pathway analyzed by network pharmacology, suggesting that they may be critical processes related to treatment.</div></div><div><h3>Conclusion</h3><div>These results provide essential perspicacity into the mechanisms of action of QFP as a promising anti-RSV drug.</div></div>\",\"PeriodicalId\":9916,\"journal\":{\"name\":\"Chinese Herbal Medicines\",\"volume\":\"16 4\",\"pages\":\"Pages 638-655\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chinese Herbal Medicines\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1674638424000765\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Herbal Medicines","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1674638424000765","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Network pharmacology, molecular docking, and untargeted metabolomics reveal molecular mechanisms of multi-targets effects of Qingfei Tongluo Plaster improving respiratory syncytial virus pneumonia
Objective
Qingfei Tongluo Plaster (QFP), an improved Chinese medicine hospital preparation, is an attractive treatment option due to its well clinical efficacy, convenience, economy, and patient compliance in the treatment of respiratory syncytial virus (RSV) pneumonia. The aim of this study was to investigate the efficacy mechanism of QFP on RSV rats from the perspective of alleviating lung inflammation and further explore the changes of serum metabolites and metabolic pathways in RSV rats under the influence of QFP.
Methods
This study used network pharmacological methods and molecular docking combined with molecular biology and metabolomics from multi-dimensional perspectives to screen and verify the therapeutic targets. Open online databases were used to speculate the gene targets of efficient ingredients and diseases. Then, we used the String database to examine the fundamental interaction of common targets of drugs and diseases. An online enrichment analysis was performed to predict the functional pathways. Molecular docking was applied to discover the binding modes between essential ingredients and crucial gene targets. Finally, we demonstrated the anti-inflammatory ability of QFP in the RSV-evoked pneumonia rat model and explained the mechanism in combination with the metabolomics results.
Results
There were 19 critical targets defined as the core targets: tumor necrosis factor (TNF), inducible nitric oxide synthase 2 (NOS2), mitogen-activated protein kinase 14 (MAPK14), g1/S-specific cyclin-D1 (CCND1), signal transducer and activator of transcription 1-alpha/beta (STAT1), proto-oncogene tyrosine-protein kinase Src (SRC), cellular tumor antigen p53 (TP53), interleukin-6 (IL6), hypoxia-inducible factor 1-alpha (HIF1A), RAC-alpha serine/threonine-protein kinase (AKT1), signal transducer and activator of transcription 3 (STAT3), heat shock protein HSP 90-alpha (HSP90AA1), tyrosine-protein kinase JAK2 (JAK2), cyclin-dependent kinase inhibitor 1 (CDKN1A), mitogen-activated protein kinase 3 (MAPK3), epidermal growth factor receptor (EGFR), myc proto-oncogene protein (MYC), protein c-Fos (FOS) and transcription factor p65 (RELA). QFP treated RSV pneumonia mainly through the phosphatidylinositol 3-kinase (PI3K)/RAC AKT pathway, HIF-1 pathway, IL-17 pathway, TNF pathway, and MAPK pathway. Animal experiments proved that QFP could effectively ameliorate RSV-induced pulmonary inflammation. A total of 28 metabolites underwent significant changes in the QFP treatment, and there are four metabolic pathways consistent with the KEGG pathway analyzed by network pharmacology, suggesting that they may be critical processes related to treatment.
Conclusion
These results provide essential perspicacity into the mechanisms of action of QFP as a promising anti-RSV drug.
期刊介绍:
Chinese Herbal Medicines is intended to disseminate the latest developments and research progress in traditional and herbal medical sciences to researchers, practitioners, academics and administrators worldwide in the field of traditional and herbal medicines. The journal's international coverage ensures that research and progress from all regions of the world are widely included.
CHM is a core journal of Chinese science and technology. The journal entered into the ESCI database in 2017, and then was included in PMC, Scopus and other important international search systems. In 2019, CHM was successfully selected for the “China Science and Technology Journal Excellence Action Plan” project, which has markedly improved its international influence and industry popularity. CHM obtained the first impact factor of 3.8 in Journal Citation Reports (JCR) in 2023.